You are here:
02 June 2017 / article

Borderline products: Cranberry products cannot be regarded as medical devices

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Decision on the qualification of cranberry products.

Borderline products cranberry products cannot be regarded as medical devices

According to the Decision, cranberry products do not fall within the definition of medical devices set out in the Medical Devices Directive.  

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Implementing Decision on the qualification of cranberry products. The Decision states that products “whose principal intended action, depending on proanthocyanidins present in cranberry (Vaccinium Macrocarpon)extract, is to prevent or treat cystitis”, are not medical devices within the meaning of Article 1 (2) (a) of the Medical Devices Directive.

Pharmacological and not a mechanical

The Decision was taken upon the request from France in accordance with Article 13 (1) (d) of the Medical Devices Directive. It also follows the European Medicines Agency’s (EMA) scientific opinion of 22 July 2016 which noted that “Products containing proanthocyanidins and/or cranberry as substance or preparation for use in urinary tract infections are currently marketed differently across the EU as food supplement, medical device or consumer product”. Furthermore, EMA concluded that the principal intended action of this group of products is most probably pharmacological and not a mechanical mode which would qualify them as medical devices.

Food supplements or medicinal products?

It will nevertheless be up to the Members States’ competent authorities to determine whether these products are food supplements or medicinal products. Should they be considered as food supplements, all health-related communications regarding those products will fall within the scope of the Nutrition and Health Claims Regulation.

The formal adoption and publication of the Decision are planned later this summer.



Energy Team achieves once again top-tier rankings in the Legal 500 EMEA

Energy Team achieves once again top-tier rankings in the Legal 500 EMEA

The Legal 500 EMEA international independent ranking directory on law firms published its annual guide on 10 April 2019. Our Belgian Energy Team has again been... read more
Loyens & Loeff in Legal 500 rankings 2019

Top scores Loyens & Loeff in Legal 500 rankings 2019

Loyens & Loeff continued its excellent rankings in the Legal 500 2019. read more
Members Belgian Data Protection Authority (finally) appointed

Members Belgian Data Protection Authority (finally) appointed

On 28 March 2019, the members of the Executive Committee of the Belgian Data Protection Authority have been appointed by the Belgian Parliament in plenary meeting.... read more
Stay informed

Don't miss out. Stay up to date about our latest news and events.

Subscribe